Learn more

STERLING DRUG INC

Overview
  • Total Patents
    6,408
About

STERLING DRUG INC has a total of 6,408 patent applications. Its first patent ever was published in 1941. It filed its patents most often in United States, Canada and United Kingdom. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are TETRAPHASE PHARMACEUTICALS INC, SEPERIC and WANDER AG DR A.

Patent filings per year

Chart showing STERLING DRUG INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Lesher George Yohe 270
#2 Singh Baldev 216
#3 Lesher George Y 195
#4 Bailey Denis Mahlon 102
#5 Crounse Nathan N 102
#6 Lesher G Y 102
#7 Surrey Alexander R 91
#8 Archer Sydney 90
#9 Clinton Raymond O 89
#10 Bell Malcolm R 85

Latest patents

Publication Filing date Title
AU1549499A Onset-hastended/enhanced analgesia
US5254592A Multiply substituted anilines, phenols and pyridines-immunomodulating agents
US5213811A Oral sustained-release drug compositions
US5106844A Imidazo[2,2-b][3]benzazepine and pyrimido[2,1-b][3]benzazepine antiarrhythmic agents
US5098901A Imidazo [1,2-b][2]benzazepine and pyrimido [1,2-b][2]benzazepine antiarrhythmic agents
US5206231A 2,5-benzodiazocine antiarrhythmic agents
US5169853A Pyridinyl-quinolone compounds, their preparation and use
US5141803A Nonwoven wipe impregnating composition
US5172512A Trap for catching mice and rats
US5338475A Carpet cleaning composition with bleach
US5109135A 2- or 3-aminomethyl-4-amino-3,4-dihydro-2H-1,4-benzoxazine intermediates
US5175177A 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US5152431A Pump apparatus for dispensing a selected one of a plurality of liquids
US5223268A Low solubility drug-coated bead compositions
CA2041379A1 Method of inhibiting human immunodeficiency virus with hydroxychloroquine
FI912037A0 Halogenubstituerade fenoxialkyl-isoxazol- och furanmellanprodukter.
IL110447A Substituted indoles
US5078698A Axial eject hypodermic syringe holder
CA2036307A1 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
US5145684A Surface modified drug nanoparticles